Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. FibroBiologics, Inc. Common Stock leads the sector with a market cap of $22.48 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
FibroBiologics, Inc. Common …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 901 |
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG |
$22.48 Million | $22.48 Million | USA | $0.81 | -9.29% | -19.80% | 3.21 Million |
| 902 |
Kadimastem Ltd
TA:KDST |
$22.18 Million | ILA8.27 Billion | Israel | ILA2794.00 | -1.13% | -8.21% | 524.25K |
| 903 |
Xbrane Biopharma AB
ST:XBRANE |
$22.17 Million | Skr206.05 Million | Sweden | Skr10.00 | -6.54% | -2.91% | 999.35K |
| 904 |
Allarity Therapeutics Inc
NASDAQ:ALLR |
$22.11 Million | $22.11 Million | USA | $1.43 | -3.38% | -9.49% | 5.32 Million |
| 905 |
Senti Biosciences Inc
NASDAQ:SNTI |
$21.87 Million | $21.87 Million | USA | $0.93 | -3.85% | -1.23% | 4.76 Million |
| 906 |
ProMIS Neurosciences Inc.
NASDAQ:PMN |
$21.87 Million | $21.87 Million | USA | $10.16 | +1.09% | +4.63% | 464.55K |
| 907 |
VistaGen Therapeutics Inc
NASDAQ:VTGN |
$21.80 Million | $21.80 Million | USA | $0.69 | +20.42% | +28.44% | 18.64 Million |
| 908 |
Resverlogix Corp.
TO:RVX |
$21.78 Million | CA$30.11 Million | Canada | CA$0.10 | +0.00% | +0.00% | 844.50K |
| 909 |
Elevation Oncology Inc
NASDAQ:ELEV |
$21.63 Million | $21.63 Million | USA | $0.37 | -2.12% | -3.95% | 26.11 Million |
| 910 |
NanoViricides Inc
NYSE MKT:NNVC |
$21.57 Million | $21.57 Million | USA | $1.64 | +5.81% | -5.75% | 10.62 Million |
| 911 |
Matricelf Ltd
TA:MTLF |
$21.46 Million | ILA8.00 Billion | Israel | ILA273.70 | +1.71% | +5.39% | 1.58 Million |
| 912 |
Hoth Therapeutics Inc
NASDAQ:HOTH |
$21.33 Million | $21.33 Million | USA | $1.12 | -25.17% | -43.72% | 515.75 Million |
| 913 |
Celularity Inc
NASDAQ:CELU |
$21.25 Million | $21.25 Million | USA | $0.74 | -4.31% | -9.26% | 3.94 Million |
| 914 |
Devonian Health Group Inc
V:GSD |
$21.12 Million | CA$29.20 Million | Canada | CA$10.50 | +5.00% | -4.46% | 19.50K |
| 915 |
Palatin Technologies, Inc. Common Stock
NASDAQ:PTN |
$21.12 Million | $21.12 Million | USA | $11.87 | -5.04% | -15.93% | 141.13K |
| 916 |
Vyne Therapeutics Inc
NASDAQ:VYNE |
$21.11 Million | $21.11 Million | USA | $0.63 | +1.75% | -3.90% | 3.59 Million |
| 917 |
Isofol Medical AB
ST:ISOFOL |
$20.90 Million | Skr194.25 Million | Sweden | Skr0.69 | -1.29% | -2.95% | 10.95 Million |
| 918 |
Neurosense Therapeutics Ltd
NASDAQ:NRSN |
$20.66 Million | $20.66 Million | USA | $0.70 | +1.75% | -7.00% | 3.10 Million |
| 919 |
VACCITECH (SP.ADR)/1
F:2AB |
$20.62 Million | €17.64 Million | Germany | €0.51 | +5.65% | +10.26% | 6.00K |
| 920 |
Nanologica AB
ST:NICA |
$20.38 Million | Skr189.37 Million | Sweden | Skr0.58 | -3.68% | +13.39% | 128.25 Million |
| 921 |
Initiator Pharma A/S
ST:INIT |
$20.33 Million | Skr188.93 Million | Sweden | Skr2.76 | +2.22% | +2.22% | 3.55 Million |
| 922 |
Nanogroup SA
WAR:NNG |
$20.27 Million | zł73.66 Million | Poland | zł2.29 | +0.22% | -0.43% | 1.10 Million |
| 923 |
Oncoinvent ASA
OL:ONCIN |
$20.26 Million | Nkr192.57 Million | Norway | Nkr43.00 | -1.83% | +2.63% | 77.06K |
| 924 |
Medivir AB
ST:MVIR |
$20.23 Million | Skr187.99 Million | Sweden | Skr1.68 | -0.83% | -0.95% | 53.80 Million |
| 925 |
Medifron DBT Co. Ltd
KQ:065650 |
$20.11 Million | ₩29.68 Billion | Korea | ₩2230.00 | +0.00% | +5.69% | 3.10 Million |
| 926 |
Sensei Biotherapeutics Inc
NASDAQ:SNSE |
$19.50 Million | $19.50 Million | USA | $14.53 | +4.91% | +11.77% | 1.30 Million |
| 927 |
Gensight Biologics SA
PA:SIGHT |
$19.18 Million | €16.41 Million | France | €0.08 | +0.00% | -1.91% | 11.99 Million |
| 928 |
Atossa Genetics Inc
NASDAQ:ATOS |
$19.12 Million | $19.12 Million | USA | $2.22 | -5.53% | -51.21% | 3.77 Million |
| 929 |
Lipocine Inc
NASDAQ:LPCN |
$18.96 Million | $18.96 Million | USA | $2.30 | +0.44% | +12.75% | 2.44 Million |
| 930 |
Urteste SA
WAR:URT |
$18.90 Million | zł68.67 Million | Poland | zł45.00 | -1.53% | +3.93% | 18.19K |
| 931 |
Advicenne
PA:ALDVI |
$18.78 Million | €16.06 Million | France | €1.10 | +0.00% | -7.54% | 1.38 Million |
| 932 |
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB |
$18.76 Million | $18.76 Million | USA | $0.46 | -3.77% | +27.71% | 80.32K |
| 933 |
Tempest Therapeutics Inc
NASDAQ:TPST |
$18.51 Million | $18.51 Million | USA | $1.25 | +0.00% | -1.57% | 2.64 Million |
| 934 |
Genus PLC
LSE:GNS |
$17.91 Million | GBX147.17 Billion | UK | GBX2216.00 | +1.74% | -0.89% | 2.37 Million |
| 935 |
EZZ Life Science Holdings Ltd
AU:EZZ |
$17.81 Million | AU$25.17 Million | Australia | AU$0.54 | +0.00% | -4.46% | 459.32K |
| 936 |
Serina Therapeutics Inc
NYSE MKT:SER |
$17.80 Million | $17.80 Million | USA | $1.98 | +4.93% | +15.12% | 1.95 Million |
| 937 |
Genolution Inc.
KQ:225220 |
$17.66 Million | ₩26.05 Billion | Korea | ₩1442.00 | +0.14% | -3.55% | 1.31 Million |
| 938 |
Quince Therapeutics, Inc.
NASDAQ:QNCX |
$17.61 Million | $17.61 Million | USA | $0.90 | -3.30% | -9.97% | 41.74 Million |
| 939 |
Werewolf Therapeutics Inc
NASDAQ:HOWL |
$17.49 Million | $17.49 Million | USA | $0.36 | -7.43% | -5.73% | 14.06 Million |
| 940 |
Passage Bio Inc
NASDAQ:PASG |
$17.48 Million | $17.48 Million | USA | $5.50 | +0.00% | +0.55% | 954.85K |
| 941 |
Marker Therapeutics Inc
NASDAQ:MRKR |
$17.47 Million | $17.47 Million | USA | $1.35 | +0.00% | -7.53% | 1.49 Million |
| 942 |
Aelis Farma SA
PA:AELIS |
$17.24 Million | €14.75 Million | France | €1.08 | -6.88% | -5.75% | 698.49K |
| 943 |
Defence Therapeutics Inc.
F:DTC |
$17.21 Million | €14.72 Million | Germany | €0.28 | -3.85% | -14.06% | 18.00K |
| 944 |
Neuroscientific Biopharmaceuticals Ltd
AU:NSB |
$16.94 Million | AU$23.95 Million | Australia | AU$0.07 | +1.41% | -17.24% | 12.12 Million |
| 945 |
Pharma Equity Group A/S Cl A
CO:PEG |
$16.90 Million | Dkr108.02 Million | Denmark | Dkr0.09 | -2.00% | +26.44% | 19.68 Million |
| 946 |
Daesung Microbiological Labs. Co. Ltd
KQ:036480 |
$16.56 Million | ₩24.43 Billion | Korea | ₩6430.00 | -0.77% | -3.74% | 400.62K |
| 947 |
Noxopharm Ltd
AU:NOX |
$16.52 Million | AU$23.35 Million | Australia | AU$0.08 | -1.30% | -6.17% | 6.99 Million |
| 948 |
Genenta Science SpA ADR
NASDAQ:GNTA |
$16.45 Million | $16.45 Million | USA | $0.70 | -1.69% | -1.63% | 2.38 Million |
| 949 |
Bioleaders Corporation
KQ:142760 |
$16.04 Million | ₩23.67 Billion | Korea | ₩606.00 | -4.72% | -10.88% | 7.67 Million |
| 950 |
Diamyd Medical AB (publ)
ST:DMYD-B |
$16.04 Million | Skr149.00 Million | Sweden | Skr1.11 | +0.72% | +2.77% | 24.91 Million |
| 951 |
Opthea Ltd
AU:OPT |
$15.49 Million | AU$21.89 Million | Australia | AU$0.02 | +6.67% | +6.67% | 1.36 Billion |
| 952 |
Zivo Bioscience Inc
NASDAQ:ZIVO |
$15.32 Million | $15.32 Million | USA | $3.69 | +0.00% | +20.98% | 14.28K |
| 953 |
CHEMOMAB THERAP. ADR/20
F:2QV0 |
$15.26 Million | €13.05 Million | Germany | €2.94 | +300.00% | +269.81% | 30.70K |
| 954 |
GT Biopharma Inc
NASDAQ:GTBP |
$15.20 Million | $15.20 Million | USA | $0.45 | -4.91% | +4.82% | 55.18 Million |
| 955 |
Xintela AB
ST:XINT |
$15.14 Million | Skr140.67 Million | Sweden | Skr0.20 | +0.00% | +0.00% | 9.35 Million |
| 956 |
Neurotech International Ltd
AU:NTI |
$14.92 Million | AU$21.08 Million | Australia | AU$0.02 | +23.08% | +33.33% | 32.11 Million |
| 957 |
Citius Pharmaceuticals Inc
NASDAQ:CTXR |
$14.87 Million | $14.87 Million | USA | $0.54 | +0.31% | -8.06% | 14.66 Million |
| 958 |
Applied Therapeutics Inc
NASDAQ:APLT |
$14.86 Million | $14.86 Million | USA | $0.10 | +0.00% | +6.96% | 245.46 Million |
| 959 |
Curis Inc
NASDAQ:CRIS |
$14.81 Million | $14.81 Million | USA | $0.38 | -8.61% | -19.17% | 5.48 Million |
| 960 |
Lexaria Bioscience Corp
NASDAQ:LEXX |
$14.60 Million | $14.60 Million | USA | $0.59 | -2.81% | -8.91% | 2.12 Million |
| 961 |
Algorae Pharmaceuticals Ltd
AU:1AI |
$14.31 Million | AU$20.23 Million | Australia | AU$0.01 | -9.09% | -16.67% | 15.40 Million |
| 962 |
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC |
$14.25 Million | $14.25 Million | USA | $6.37 | -5.98% | -17.18% | 2.26 Million |
| 963 |
GENENTA SCIENCE(SP.ADR)/1
F:K5F |
$14.25 Million | €12.18 Million | Germany | €0.52 | +0.00% | +10.17% | 15.96K |
| 964 |
Oxford Nanopore Technologies Ltd
LSE:ONT |
$14.06 Million | GBX115.53 Billion | UK | GBX118.80 | +0.51% | -9.24% | 27.82 Million |
| 965 |
Proteomics International Laboratories Ltd
AU:PIQ |
$14.03 Million | AU$19.82 Million | Australia | AU$0.12 | +0.00% | -11.11% | 7.36 Million |
| 966 |
Quantum BioPharma Ltd.
NASDAQ:QNTM |
$13.99 Million | $13.99 Million | USA | $3.64 | -1.62% | -10.12% | 10.97 Million |
| 967 |
Exicure Inc
NASDAQ:XCUR |
$13.83 Million | $13.83 Million | USA | $2.17 | -22.22% | -27.42% | 516.66K |
| 968 |
GENFLOW BIOSCIENCES PLC
F:WQ5 |
$13.66 Million | €11.68 Million | Germany | €0.02 | +0.00% | +0.00% | 0.00 |
| 969 |
BTC Health Ltd
AU:BTC |
$13.66 Million | AU$19.30 Million | Australia | AU$0.05 | +0.00% | -1.82% | 453.70K |
| 970 |
PROBIOTIX HEALTH LS-05
F:X90 |
$13.59 Million | €11.63 Million | Germany | €0.07 | +0.00% | +0.00% | 0.00 |
| 971 |
In8bio Inc
NASDAQ:INAB |
$13.59 Million | $13.59 Million | USA | $1.38 | -0.72% | -4.17% | 1.55 Million |
| 972 |
Elicera Therapeutics AB
ST:ELIC |
$13.58 Million | Skr126.19 Million | Sweden | Skr2.60 | +2.36% | +2.36% | 9.71 Million |
| 973 |
Biotechnology Assets S.A.
MC:BST |
$13.52 Million | €11.57 Million | Spain | €0.25 | -0.41% | -2.39% | 2.78 Million |
| 974 |
Simris Alg AB (publ)
ST:SIMRIS-B |
$13.39 Million | Skr124.45 Million | Sweden | Skr0.09 | +0.44% | +4.30% | 5.98 Million |
| 975 |
COCRYSTAL PHARMA NEW O.N.
F:8CC |
$13.30 Million | €11.37 Million | Germany | €0.83 | -1.79% | +1.85% | 0.00 |
| 976 |
BioLineRx Ltd
NASDAQ:BLRX |
$13.27 Million | $13.27 Million | USA | $3.05 | -6.01% | -6.15% | 2.25 Million |
| 977 |
Cocrystal Pharma Inc
NASDAQ:COCP |
$13.05 Million | $13.05 Million | USA | $0.95 | -4.43% | -6.32% | 2.79 Million |
| 978 |
Moleculin Biotech Inc
NASDAQ:MBRX |
$13.02 Million | $13.02 Million | USA | $2.70 | -0.37% | +9.31% | 6.50 Million |
| 979 |
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD |
$12.93 Million | $12.93 Million | USA | $5.53 | -5.63% | +14.97% | 1.28 Million |
| 980 |
Poxel SA
PA:POXEL |
$12.92 Million | €11.05 Million | France | €0.21 | -0.96% | -8.65% | 5.61 Million |
| 981 |
Biocardia Inc
NASDAQ:BCDA |
$12.91 Million | $12.91 Million | USA | $0.87 | +4.12% | -5.72% | 165.03 Million |
| 982 |
Cyclerion Therapeutics Inc
NASDAQ:CYCN |
$12.90 Million | $12.90 Million | USA | $3.18 | +0.00% | +5.65% | 1.00 Million |
| 983 |
NextCell Pharma AB
ST:NXTCL |
$12.83 Million | Skr119.19 Million | Sweden | Skr1.07 | +1.90% | -0.74% | 7.54 Million |
| 984 |
Biovie Inc
NASDAQ:BIVI |
$12.82 Million | $12.82 Million | USA | $1.78 | +7.23% | +6.59% | 2.45 Million |
| 985 |
NFL Biosciences SAS
PA:ALNFL |
$12.80 Million | €10.95 Million | France | €0.86 | -4.00% | -8.57% | 1.85 Million |
| 986 |
Theriva Biologics Inc.
NYSE MKT:TOVX |
$12.74 Million | $12.74 Million | USA | $0.28 | -5.58% | +7.18% | 329.47 Million |
| 987 |
Jasper Therapeutics Inc
NASDAQ:JSPR |
$12.66 Million | $12.66 Million | USA | $0.45 | -5.87% | -3.35% | 14.04 Million |
| 988 |
Oncozenge AB
ST:ONCOZ |
$12.64 Million | Skr117.44 Million | Sweden | Skr8.36 | +4.50% | +21.51% | 1.43 Million |
| 989 |
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ:GDTC |
$12.60 Million | $12.60 Million | USA | $1.11 | -3.48% | -3.48% | 655.50K |
| 990 |
Vyome Holdings, Inc.
NASDAQ:HIND |
$12.42 Million | $12.42 Million | USA | $2.20 | +1.38% | +0.46% | 584.34K |
| 991 |
OSR Holdings Inc
NASDAQ:OSRH |
$12.37 Million | $12.37 Million | USA | $0.37 | -2.89% | -7.32% | 26.39 Million |
| 992 |
Phio Pharmaceuticals Corp
NASDAQ:PHIO |
$12.31 Million | $12.31 Million | USA | $1.06 | -3.64% | -2.75% | 3.29 Million |
| 993 |
SeaStar Medical Holding Corporation
NASDAQ:ICU |
$12.15 Million | $12.15 Million | USA | $3.04 | -2.88% | +4.83% | 2.09 Million |
| 994 |
CEL-SCI Corp
NYSE MKT:CVM |
$12.01 Million | $12.01 Million | USA | $1.42 | -2.07% | +9.23% | 17.92 Million |
| 995 |
OPTHEA LTD
F:UKJ |
$11.99 Million | €10.26 Million | Germany | €0.01 | +7.14% | -25.00% | 0.00 |
| 996 |
Lunai Bioworks Inc.
NASDAQ:LNAI |
$11.97 Million | $11.97 Million | USA | $2.85 | +9.00% | +20.04% | 9.12 Million |
| 997 |
Polyrizon Ltd. Ordinary Shares
NASDAQ:PLRZ |
$11.93 Million | $11.93 Million | USA | $11.45 | +5.72% | -8.55% | 834.20K |
| 998 |
Chemomab Therapeutics Ltd DRC
NASDAQ:CMMB |
$11.81 Million | $11.81 Million | USA | $1.64 | +3.80% | -9.38% | 1.14 Million |
| 999 |
Alligator Bioscience AB
ST:ATORX |
$11.77 Million | Skr109.42 Million | Sweden | Skr0.17 | +1.28% | -11.66% | 101.56 Million |
| 1000 |
Clal Biotechnology Industries Ltd
TA:CBI |
$11.61 Million | ILA4.33 Billion | Israel | ILA27.60 | +5.34% | -4.17% | 2.53 Million |
| 1001 |
ABERA BIOSCIENCE AB
F:8WK |
$11.56 Million | €9.89 Million | Germany | €0.72 | -1.10% | +16.94% | 0.00 |
| 1002 |
Hookipa Pharma Inc
NASDAQ:HOOK |
$11.47 Million | $11.47 Million | USA | $1.15 | +0.00% | +0.00% | 52.46K |
| 1003 |
Pasithea Therapeutics Corp
NASDAQ:KTTA |
$11.42 Million | $11.42 Million | USA | $0.51 | -8.93% | -11.40% | 10.70 Million |
| 1004 |
Sirona Biochem Corp
V:SBM |
$11.23 Million | CA$15.53 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 1005 |
BioLine RX Ltd
TA:BLRX |
$11.20 Million | ILA4.18 Billion | Israel | ILA1.60 | +6.67% | +0.00% | 169.28 Million |
| 1006 |
Curative Biotechnology Inc
NYSE MKT:CUBT |
$11.10 Million | $11.10 Million | USA | $1.45 | -5.84% | -6.45% | 20.10K |
| 1007 |
IRLAB Therapeutics AB (publ)
ST:IRLAB-A |
$10.96 Million | Skr101.83 Million | Sweden | Skr1.20 | +0.00% | -3.23% | 3.81 Million |
| 1008 |
Portage Biotech Inc
NASDAQ:PRTG |
$10.71 Million | $10.71 Million | USA | $4.70 | -0.84% | -10.13% | 35.48 Million |
| 1009 |
Kiora Pharmaceuticals Inc
NASDAQ:KPRX |
$10.68 Million | $10.68 Million | USA | $2.62 | +6.50% | +1.55% | 983.16K |
| 1010 |
Cellectar Biosciences Inc
NASDAQ:CLRB |
$10.39 Million | $10.39 Million | USA | $2.45 | +4.70% | -2.39% | 4.97 Million |
| 1011 |
Eterna Therapeutics Inc
NASDAQ:ERNA |
$10.38 Million | $10.38 Million | USA | $6.10 | -3.17% | -17.46% | 5.07 Million |
| 1012 |
GlycoMimetics Inc
NASDAQ:GLYC |
$10.13 Million | $10.13 Million | USA | $0.16 | +0.00% | +0.00% | 1.07 Million |
| 1013 |
Argenica Therapeutics Ltd
AU:AGN |
$10.00 Million | AU$14.13 Million | Australia | AU$0.11 | -8.33% | -15.38% | 6.90 Million |
| 1014 |
Intensity Therapeutics, Inc. Common stock
NASDAQ:INTS |
$9.92 Million | $9.92 Million | USA | $3.71 | -5.60% | -1.85% | 668.44K |
| 1015 |
CalciMedica, Inc. Common Stock
NASDAQ:CALC |
$9.90 Million | $9.90 Million | USA | $0.86 | -1.38% | -10.44% | 7.10 Million |
| 1016 |
Pharmena S.A.
WAR:PHR |
$9.84 Million | zł35.75 Million | Poland | zł3.21 | +0.63% | +0.94% | 59.71K |
| 1017 |
Orgenesis Inc
NASDAQ:ORGS |
$9.83 Million | $9.83 Million | USA | $1.95 | +0.00% | +0.00% | 2.56K |
| 1018 |
AcouSort AB
ST:ACOU |
$9.82 Million | Skr91.22 Million | Sweden | Skr4.31 | +2.38% | -1.82% | 1.04 Million |
| 1019 |
Biomind Labs Inc
NEO:BMND |
$9.70 Million | CA$13.40 Million | Canada | CA$0.19 | +76.19% | +48.00% | 137.22K |
| 1020 |
Entero Therapeutics, Inc.
NASDAQ:ENTO |
$9.58 Million | $9.58 Million | USA | $2.85 | -5.32% | -13.11% | 3.88 Million |
| 1021 |
Adaptimmune Therapeutics Plc
NASDAQ:ADAP |
$9.54 Million | $9.54 Million | USA | $0.04 | -29.13% | -50.34% | 2.65 Billion |
| 1022 |
ESSA Pharma Inc
NASDAQ:EPIX |
$9.52 Million | $9.52 Million | USA | $0.20 | -1.85% | +5.34% | 77.22 Million |
| 1023 |
Biovica International AB (publ)
ST:BIOVIC-B |
$9.33 Million | Skr86.72 Million | Sweden | Skr0.32 | -9.48% | -12.74% | 13.18 Million |
| 1024 |
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B |
$9.27 Million | Skr86.16 Million | Sweden | Skr3.62 | +3.13% | +1.40% | 223.67K |
| 1025 |
Annexin Pharmaceuticals AB
ST:ANNX |
$9.27 Million | Skr86.12 Million | Sweden | Skr12.20 | +0.00% | -6.15% | 173.45K |
| 1026 |
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI |
$9.16 Million | $9.16 Million | USA | $0.85 | +5.09% | +6.25% | 166.08K |
| 1027 |
AEON Biopharma, Inc.
NYSE MKT:AEON |
$9.05 Million | $9.05 Million | USA | $0.78 | -5.38% | -3.00% | 1.85 Million |
| 1028 |
Aprea Therapeutics Inc
NASDAQ:APRE |
$9.03 Million | $9.03 Million | USA | $0.73 | +4.39% | -0.68% | 3.41 Million |
| 1029 |
BioRestorative Therapies Inc
NASDAQ:BRTX |
$9.00 Million | $9.00 Million | USA | $0.35 | -9.69% | -2.46% | 610.69 Million |
| 1030 |
Celyad SA
BR:CYAD |
$8.95 Million | €7.66 Million | Belgium | €0.26 | +0.00% | -6.38% | 361.14K |
| 1031 |
Chromocell Therapeutics Corporation
NYSE MKT:CHRO |
$8.90 Million | $8.90 Million | USA | $22.46 | -5.03% | -0.18% | 214.56K |
| 1032 |
Oxford BioMedica PLC
LSE:OXB |
$8.83 Million | GBX72.57 Billion | UK | GBX601.00 | -0.50% | -3.84% | 6.89 Million |
| 1033 |
XTL Biopharmaceuticals Ltd ADR
NASDAQ:XTLB |
$8.80 Million | $8.80 Million | USA | $2.45 | -2.59% | +2.73% | 282.27K |
| 1034 |
Marvel Biosciences Corp
V:MRVL |
$8.70 Million | CA$12.03 Million | Canada | CA$0.22 | +7.50% | +7.50% | 2.49 Million |
| 1035 |
COSCIENS Biopharma Inc.
NASDAQ:CSCI |
$8.64 Million | $8.64 Million | USA | $3.15 | +10.14% | +23.05% | 75.06K |
| 1036 |
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN |
$8.60 Million | $8.60 Million | USA | $1.26 | -59.35% | -72.31% | 27.78 Million |
| 1037 |
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS |
$8.53 Million | $8.53 Million | USA | $0.24 | -0.17% | +1.77% | 362.22 Million |
| 1038 |
MetaVia Inc.
NASDAQ:MTVA |
$8.52 Million | $8.52 Million | USA | $1.65 | -3.51% | -25.68% | 222.86 Million |
| 1039 |
BioLight Life Sciences Ltd
TA:BOLT |
$8.43 Million | ILA3.15 Billion | Israel | ILA347.70 | -0.37% | +19.81% | 598.35K |
| 1040 |
Cambium Bio Ltd
AU:CMB |
$8.41 Million | AU$11.89 Million | Australia | AU$0.44 | +0.00% | +3.57% | 131.65K |
| 1041 |
Bolt Biotherapeutics
NASDAQ:BOLT |
$8.28 Million | $8.28 Million | USA | $4.31 | -6.10% | -8.69% | 688.17K |
| 1042 |
Creative Medical Technology Holdings Inc
NASDAQ:CELZ |
$8.28 Million | $8.28 Million | USA | $2.24 | -6.28% | +3.25% | 1.39 Million |
| 1043 |
Visgeneer
TWO:4197 |
$8.27 Million | NT$262.57 Million | Taiwan | NT$8.70 | -3.12% | -2.25% | 2.00 Million |
| 1044 |
Spago Nanomedical AB
ST:SPAGO |
$8.26 Million | Skr76.74 Million | Sweden | Skr0.12 | -3.33% | +5.45% | 15.94 Million |
| 1045 |
Turnstone Biologics Corp. Common Stock
NASDAQ:TSBX |
$8.21 Million | $8.21 Million | USA | $0.36 | +0.00% | +1.37% | 3.19 Million |
| 1046 |
Immuron Ltd
AU:IMC |
$8.09 Million | AU$11.43 Million | Australia | AU$0.04 | -2.78% | -16.67% | 10.91 Million |
| 1047 |
Synaptogenix Inc
NASDAQ:SNPX |
$8.09 Million | $8.09 Million | USA | $5.82 | -11.08% | -9.77% | 6.42 Million |
| 1048 |
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH |
$8.07 Million | $8.07 Million | USA | $0.63 | -10.00% | -5.83% | 16.33 Million |
| 1049 |
Quoin Pharmaceuticals Ltd DRC
NASDAQ:QNRX |
$8.04 Million | $8.04 Million | USA | $4.46 | -4.09% | -2.41% | 814.17K |
| 1050 |
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX |
$7.99 Million | $7.99 Million | USA | $0.32 | -5.19% | +4.81% | 1.77 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries